Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    16684987 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)
Condition: Medullary Thyroid Carcinoma
Interventions: Drug: Bortezomib;   Drug: Vandetanib
2 Completed
Has Results
A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)
Conditions: Solid Tumor;   Anaplastic Thyroid Cancer
Interventions: Drug: Crolibulin;   Drug: Cisplatin
3 Completed
Has Results
A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin
Condition: Thyroid Neoplasm
Interventions: Drug: Valproic Acid;   Drug: Liothyronine Sodium

Study has passed its completion date and status has not been verified in more than two years.